The different metabolism of morusin in various species and its potent inhibition against UDP-glucuronosyltransferase (UGT) and cytochrome p450 (CYP450) enzymes

References

• Chi YS, Jong HG, Son KH, et al. (2001). Effects of naturally occurring prenylated flavonoids on enzymes metabolizing arachdonic acid: cyclooxygenases and lipoxygenases. Biochem Pharmacol 62:1185–91
   PubMed Web of Science ®Google Scholar
• Grimm S, Einolf HJ, Hall SD, et al. (2009). The conduct of in vitro studies to address time dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America. Drug Metab Dispos 37:1355–70
   PubMed Web of Science ®Google Scholar
• Jiang RW, Wang Y, Gao H, et al. (2009). Molecular structures and π–π interactions of quercitrin and morusin hydroperoxide. J Mol Struct 920:383–6
   Web of Science ®Google Scholar
• Kudo T, Endo Y, Taguchi R, et al. (2015). Metronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytes. Xenobiotica 45:413–19
   PubMed Web of Science ®Google Scholar
• Lee HJ, Ryu J, Park SH, et al. (2014). Effects of Morus alba L. and natural products including morusin on in vivo secretion and in vitro production of airway MUC5AC mucin. Bull Natl Tuberc Respir Dis Assoc 77:65–72
   Google Scholar
• Li XQ, Björkman A, Andersson TB, et al. (2003). Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. Eur J Clin Pharmacol 59:429–42
   PubMed Web of Science ®Google Scholar
• Li W, Liu Y, He YQ, et al. (2008). Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes. Xenobiotica 38:1551–65
   PubMed Web of Science ®Google Scholar
• Lin WL, Lai DY, Lee YJ, et al. (2015). Antitumor progression potential of morusin suppressing STAT3 and NFκB in human hepatoma SK-Hep1 cells. Toxicol Lett 232:490–8
   PubMed Web of Science ®Google Scholar
• Liu Y, Ma H, Zhang JW, et al. (2006). Influence of ginsenoside Rh1 and F1 on human cytochrome p450 enzymes. Planta Med 72:126–31
   PubMed Web of Science ®Google Scholar
• Liu Y, Ramírez J, House L, et al. (2010). Comparison of the drug-drug interactions potential of erlotinib and gefitinib via inhibition of UDP-glucuronosyltransferases. Drug Metab Dispos 38:32–9
   PubMed Web of Science ®Google Scholar
• Liu YP, She MQ, Wu ZC, et al. (2011). The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors. J Enzyme Inhib Med Chem 26:386–93
   PubMed Web of Science ®Google Scholar
• Ma XC, Ning J, Ge GB, et al. (2011). Comparative metabolism of cinobufagin in liver microsomes from mouse, rat, dog, minipig, monkey, and human. Drug Metab Dispos 39:675–82
   PubMed Web of Science ®Google Scholar
• Meza-Junco J, Chu QS, Christensen O, et al. (2009). UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib. Cancer Chemother Pharmacol 65:1–4
   PubMed Web of Science ®Google Scholar
• Milackova I, Prnova MS, Majekova M, et al. (2015). 2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent. J Enzyme Inhib Med Chem 30:107–13
   PubMed Web of Science ®Google Scholar
• Naritomi Y, Terashita S, Kimura S, et al. (2001). Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver macrodomes from animals and humans. Drug Metab Dispos 29:1316–24
   PubMed Web of Science ®Google Scholar
• Nomura T, Fukai T, Yamada S, et al. (1978). Studies on the constituents of the cultivated Mulberry Tree. I. Three new prenylflavones from the root bark of Morus alba L. Chem Pharm Bull 26:1394–1402
   Web of Science ®Google Scholar
• Shan L, Yang S, Zhang G, et al. (2014). Comparison of the inhibitory potential of bavachalcone and corylin against UDP-glucuronosyltransferases. Evid Based Complement Alternat Med 2014:958937. doi:10.1155/2014/958937
   PubMed Web of Science ®Google Scholar
• Sohn HY, Son KH, Kwon CS, et al. (2004). Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai. Phytomedicine 11:666–72
   PubMed Web of Science ®Google Scholar
• Sun DX, Fang ZZ, Zhang YY, et al. (2010). Inhibitory effects of curcumenol on human liver cytochrome p450 enzymes. Phytother Res 24:1213–16
   PubMed Web of Science ®Google Scholar
• Syahdi RR, Munim A, Suhartanto H, et al. (2012). Virtual screening of Indonesian herbal database as HIV-1 reverse transcriptase inhibitor. Bioinformation 8:1206–10
   PubMedGoogle Scholar
• Turpeinen M, Ghiciuc C, Opritoui M, et al. (2007). Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: a comparative study in vitro. Xenobiotica 12:1367–77
   Web of Science ®Google Scholar
• Wang L, Guo H, Yang L, et al. (2013). Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NFκB activity and apoptosis induction. Mol Cell Biochem 379:7–18
   PubMed Web of Science ®Google Scholar
• Woolf AD, Watson WA, Smolinske S, et al. (2005). The severity of toxic reactions to ephedra: comparisons to other botanical products and national trends from 1993–2002. Clin Toxicol (Phila) 43:347–55
   PubMed Web of Science ®Google Scholar
• Yao Y, Lin G, Xie Y, et al. (2014). Preformulation studies of myricetin: a natural antioxidant flavonoid. Pharmazie 69:19–26
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ding T, Diao T, et al. (2015). Effects of polygonum multiflorum on the activity of cytochrome P450 isoforms in rats. Pharmazie 70:47–54
   PubMed Web of Science ®Google Scholar
• Zheng YF, Bae SH, Choi EJ, et al. (2014). Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition. Food Chem Toxicol 68:117–27
   PubMed Web of Science ®Google Scholar
• Ż ołnierczyk AK, Mączka WK, Grabarczyk M, et al. (2015). Isoxanthohumol—biologically active hop flavonoid. Fitoterapia 103:71–82
   Google Scholar